Our News

CN Bio FDA collaboration expanded

The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications Extension aims to evaluate CN Bio’s PhysioMimix lung-on-a-chip platform in addition to deepening existing research collaboration for liver studies...

read more

Flowing to the Beat of Your Heart

How Mimicking Blood Flow Makes Organ-on-a-Chip Technology Even More Life-like With every beat of your heart,  blood rushes through your body. Some floods your arteries traveling from the lungs back to the heart. Some squeezes almost single-file, one frisbee-shaped...

read more

Life in the Fastlane

How a Partnership between the FDA and Organ-on-a-Chip Developers Has the Potential to Fast-track Drug Development From a small discovery in a research lab to a capsule on a pharmacist’s shelf – the path of drug development is a long one. Whilst scientists discover or...

read more
About CN Bio

CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.

As an EOE employer, CN Bio will not discriminate in its employment practices due to an applicant’s race, color, religion, sex, national origin, sexual orientation, gender identity, disability or veteran status.